These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25761670)

  • 21. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
    J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts.
    Bi Y; Nielsen KL; Kilts TM; Yoon A; A Karsdal M; Wimer HF; Greenfield EM; Heegaard AM; Young MF
    Bone; 2006 Jun; 38(6):778-86. PubMed ID: 16364709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ferulic acid, a dietary polyphenol suppresses osteoclast differentiation and bone erosion via the inhibition of RANKL dependent NF-κB signalling pathway.
    Doss HM; Samarpita S; Ganesan R; Rasool M
    Life Sci; 2018 Aug; 207():284-295. PubMed ID: 29908722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenosine A
    Mediero A; Wilder T; Shah L; Cronstein BN
    FASEB J; 2018 Jul; 32(7):3487-3501. PubMed ID: 29394106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MST2 kinase regulates osteoblast differentiation by phosphorylating and inhibiting Runx2 in C2C12 cells.
    Won GW; Sung M; Lee Y; Lee YH
    Biochem Biophys Res Commun; 2019 May; 512(3):591-597. PubMed ID: 30910359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling.
    Samee N; Geoffroy V; Marty C; Schiltz C; Vieux-Rochas M; Levi G; de Vernejoul MC
    Am J Pathol; 2008 Sep; 173(3):773-80. PubMed ID: 18669617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-17/20a inhibits glucocorticoid-induced osteoclast differentiation and function through targeting RANKL expression in osteoblast cells.
    Shi C; Qi J; Huang P; Jiang M; Zhou Q; Zhou H; Kang H; Qian N; Yang Q; Guo L; Deng L
    Bone; 2014 Nov; 68():67-75. PubMed ID: 25138550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear Factor-Kappa B Regulation of Osteoclastogenesis and Osteoblastogenesis.
    Boyce BF; Li J; Yao Z; Xing L
    Endocrinol Metab (Seoul); 2023 Oct; 38(5):504-521. PubMed ID: 37749800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast-osteoblast uncoupling.
    Li S; Liu Q; Wu D; He T; Yuan J; Qiu H; Tickner J; Zheng SG; Li X; Xu J; Rong L
    Cell Death Dis; 2020 Sep; 11(9):762. PubMed ID: 32938907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Water extract of Rumex crispus prevents bone loss by inhibiting osteoclastogenesis and inducing osteoblast mineralization.
    Shim KS; Lee B; Ma JY
    BMC Complement Altern Med; 2017 Oct; 17(1):483. PubMed ID: 29070038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
    Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
    BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Establish mouse osteoblast -osteoclast cell co-culture system in a Transwell chamber].
    Mo GY; Zhang SC; Li YX; Guo HZ; Guo DQ; Li DX; Tang YC; Mo L; Luo PJ; Ma YH
    Zhongguo Gu Shang; 2018 Mar; 31(3):241-247. PubMed ID: 29600675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-c-fms Antibody Prevents Osteoclast Formation and Bone Resorption in Co-Culture of Osteoblasts and Osteoclast Precursors In Vitro and in Ovariectomized Mice.
    Nara Y; Kitaura H; Ogawa S; Shen WR; Qi J; Ohori F; Noguchi T; Marahleh A; Pramusita A; Kinjo R; Mizoguchi I
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway.
    Zheng L; Gao J; Jin K; Chen Z; Yu W; Zhu K; Huang W; Liu F; Mei L; Lou C; He D
    FASEB J; 2019 Jun; 33(6):7667-7683. PubMed ID: 30893559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acvr1 deletion in osteoblasts impaired mandibular bone mass through compromised osteoblast differentiation and enhanced sRANKL-induced osteoclastogenesis.
    Hu Y; Hao X; Liu C; Ren C; Wang S; Yan G; Meng Y; Mishina Y; Shi C; Sun H
    J Cell Physiol; 2021 Jun; 236(6):4580-4591. PubMed ID: 33251612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.
    Wang L; Liu S; Zhao Y; Liu D; Liu Y; Chen C; Karray S; Shi S; Jin Y
    Cell Death Differ; 2015 Oct; 22(10):1654-64. PubMed ID: 25744024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IDH2 deficiency increases bone mass with reduced osteoclastogenesis by limiting RANKL expression in osteoblasts.
    Lee SH; Lee SH; Lee JH; Park JW; Kim JE
    Bone; 2019 Dec; 129():115056. PubMed ID: 31479775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autophagy in osteoblasts is involved in mineralization and bone homeostasis.
    Nollet M; Santucci-Darmanin S; Breuil V; Al-Sahlanee R; Cros C; Topi M; Momier D; Samson M; Pagnotta S; Cailleteau L; Battaglia S; Farlay D; Dacquin R; Barois N; Jurdic P; Boivin G; Heymann D; Lafont F; Lu SS; Dempster DW; Carle GF; Pierrefite-Carle V
    Autophagy; 2014; 10(11):1965-77. PubMed ID: 25484092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.